5A9-30762-69308

3 vaccinations 6 coded responses 25 check-ins 6 free-text entries 2 call cases

Sex: Female
Age at first dose: 31-35
ZIP prefix: 622 / IL
Registered: 2021-04-06

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-06
Registered in v-safe
2021-04-06
Dose 1 — Pfizer-BioNTech
2021-04-06
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · Fever · Fatigue or tiredness

Adult check-in
2021-04-07
Survey response — days 1–6 daily, dose 1
MedDRA: Insomnia — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work

Free text: Insomnia

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-08
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-09
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-10
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-11
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-12
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-13
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-04-20
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-04-27
Dose 2 — Pfizer-BioNTech
2021-04-27
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-04-28
Survey response — days 1–6 daily, dose 2
MedDRA: Unevaluable event — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work

Free text: My usual temperature is around 97.9Â°F

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-29
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-04-30
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Headache

Adult check-in
2021-05-01
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-05-02
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache, Fatigue or tiredness

Adult check-in
2021-05-03
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-05-04
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-05-12
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-18
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-25
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-06-02
Survey response — day 35, dose 2
MedDRA: Rhinorrhoea — Feeling: Fair

Free text: Runny nose

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-08
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-27
Survey response — 3 months, dose 2
MedDRA: Productive cough — Feeling: Good

Free text: Persistent phlegm

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-11-17
Dose 3 — Pfizer-BioNTech
Co-administered: Flu
2022-02-18
Survey response — 3 months, dose 3
MedDRA: Chillblains, Decreased appetite, Dysmenorrhoea, Headache, Office visit, Peripheral coldness, Self-medication, Sleep disorder, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Symptoms: Significantly more painful menstrual cramps that are difficult to relieve pain (ibuprofen, acetaminophen, thermacare heat wraps), possible circulation issues (cold fingers/toes, chilblains on toes), reduced appetite, headaches, disrupted sleep · Healthcare visit (other): Discussed with primary care

MedDRA releases: 2024-11 · check-in free text available
2022-02-18
Report sent to call center — 3 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-02-24
Call successful
Participant prefers to complete VAERS report online
2022-11-21
Survey response — 12 months, dose 3
MedDRA: Food allergy, Hypersensitivity, Menstruation irregular, Pain, Urticaria — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Food and environmental sensitivities that had not previously caused allergic responses Disrupted menstrual cycle and increased pain (undergoing treatment) Hives

MedDRA releases: 2024-11 · check-in free text available
2022-11-21
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-11-22
Call successful
Participant prefers to complete VAERS report online

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-06	Pfizer-BioNTech
2	2021-04-27	Pfizer-BioNTech
3	2021-11-17	Pfizer-BioNTech	Flu

Call center

2 call center cases

2 successful

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 1

2021-04-07

Systemic reaction (other): Insomnia

Release 8 — days 1–6 daily, dose 2

2021-04-28

Systemic reaction (other): My usual temperature is around 97.9Â°F

Release 8 — day 35, dose 2

2021-06-02

Symptoms: Runny nose

Release 9 — 3 months, dose 2

2021-07-27

Symptoms: Persistent phlegm

Release 11 — 3 months, dose 3

2022-02-18

Symptoms: Significantly more painful menstrual cramps that are difficult to relieve pain (ibuprofen, acetaminophen, thermacare heat wraps), possible circulation issues (cold fingers/toes, chilblains on toes), reduced appetite, headaches, disrupted sleep

Healthcare visit (other): Discussed with primary care

Release 12 — 12 months, dose 3

2022-11-21

Symptoms: Food and environmental sensitivities that had not previously caused allergic responses Disrupted menstrual cycle and increased pain (undergoing treatment) Hives

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	·	·	✓
SD	Chillblains	·	·	✓
SD	Decreased appetite	·	·	✓
SD	Dysmenorrhoea	·	·	✓
SD	Food allergy	·	·	✓
SD	Headache	·	·	✓
SD	Hypersensitivity	·	·	✓
SD	Menstruation irregular	·	·	✓
SD	Pain	·	·	✓
SD	Peripheral coldness	·	·	✓
SD	Productive cough	✓	·	✓
SD	Rhinorrhoea	✓	✓	✓
SD	Self-medication	·	·	✓
SD	Sleep disorder	·	·	✓
SD	Unevaluable event	·	·	✓
SD	Urticaria	·	·	✓
SRO	Insomnia	✓	✓	✓
SRO	Unevaluable event	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release